TanakaRSasajimaYTsudaH, et al. Human epidermal growth factor receptor 2 protein overexpression and gene amplification in extramammary Paget disease. Br J Dermatol. 2013;168(6):1259-1266. doi:10.1111/bjd.12249
3.
KibbiNOwenJLWorleyB, et al. Evidence-based clinical practice guidelines for extramammary Paget disease. JAMA Oncol. 2022;8(4):618-628. doi:10.1001/jamaoncol.2021.7148
4.
KibbiNOwenJLWorleyB, et al. Anatomic subtype differences in extramammary Paget disease: a meta-analysis. JAMA Dermatol. 2024;160(4):417-424. doi:10.1001/jamadermatol.2024.0001
5.
HiraiITaneseKNakamuraY, et al. Phase II clinical trial of docetaxel and trastuzumab for HER2-positive advanced extramammary Paget’s disease (EMPD-HER2DOC). Oncologist. 2024;29:e1201-e1208. doi:10.1093/oncolo/oyae097
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
